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Emphysematous pyelonephritis (EPN) is a rare, severe, and gas-forming 
infection of the kidney. EPN is common in patients with diabetes mellitus 
and/or urinary tract obstruction. EPN rarely occurs in patients with end-
stage renal disease, and is rarely caused by non-typhoidal Salmonella. 
This is a case report of end-stage renal disease in a 28-year-old woman 
who refused regular hemodialysis. She presented with fever, abdominal 
pain and right flank pain. Unenhanced computed tomography showed air 
within the right kidney. Salmonella group D was isolated from the drain-
age. The patient was successfully treated with antibiotics and percutaneous 
catheter drainage. To our knowledge, this is the first case report in the 
literature of EPN caused by Salmonella in a patient with end-stage renal 
disease who did not have diabetes mellitus or urinary tract obstruction. 
[Tzu Chi Med J 2007;19(4):249–252]
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1. Introduction
Emphysematous pyelonephritis (EPN) is a rare, severe 
necrotizing infection of the kidney that leads to accu-
mulation of gas in the collecting system, renal paren-
chyma, and perinephric tissue [1–4]. In general, EPN 
is common in patients with diabetes mellitus (DM) and 
in nondiabetic patients with urinary tract obstruction 
(UTO) [1–12]. EPN rarely occurs in end-stage renal 
disease (ESRD), and only two such cases have been 
reported [13,14]. In addition, urinary tract infection 
(UTI) caused by Salmonella is rare [15–17]. Only one 
case of EPN induced by Salmonella has been reported 
in a renal transplant recipient [18]. Here, we present 
the first case report in the literature of EPN caused by 
Salmonella in a patient with ESRD who did not have 
DM or UTO; it was successfully treated with antibiotics 
plus percutaneous catheter drainage (PCD).
2. Case report
A 28-year-old woman was brought to the emergency 
department with a 7-day history of right flank pain, 
fever, dyspnea and oliguria. She was known to have 
chronic renal failure and creation of an arteriovenous 
shunt had been recommended about 5 years ago. 
However, she did not have regular outpatient clinic 
follow-up and took Chinese herbs during this period. 
On physical examination, she was in acute distress. 
She was febrile with a temperature of 38.4°C, pulse 
rate of 103 beats/min, respiratory rate of 25 breaths/
min, and blood pressure of 163/83 mmHg. Tender-
ness was noted at the right flank and right cost o-
vertebral angle when percussed. Biochemistry data 
showed blood urea nitrogen of 237 mg/dL, creatinine 
of 33.1 mg/dL, sodium of 130 mmol/L, potassium of 
6.3 mmol/L, glucose of 126 mg/dL, glutamic oxaloace-
tic transaminase of 17 IU/L, and C-reactive protein of 
2.85 mg/dL. Arterial blood gases were pH 7.286, bicar-
bonate 11.7 mmol/L, and pCO2 24.4 mmHg. Complete 
blood count showed white blood cell (WBC) 9.45 × 
103/μL with 93% segmented neutrophils, 1% lympho-
cytes, 6% monocytes, and no bands; hematocrit 9.1%; 
and platelets 179 × 103/μL. Urinalysis showed protein 
> 300 mg/dL, and glucose of 100 mg/dL. Microscopic 
examination revealed WBCs 23–25/high-powered field 
(HPF), and red blood cells 6–8/HPF. Plain abdominal 
radiograph revealed no significant finding. Unenhanced 
computed tomography (CT) of the abdo men showed 
air accumulation within a subcapsular collection at the 
posterior aspect of the enlarged right kidney (Fig. 1A).
Under the impression of renal failure with hyperka-
lemia and general edema, emergency hemodialysis 
was performed. In addition, a percutaneous catheter 
was inserted into the subcapsular collection in the 
right kidney (Fig. 1B). The drainage culture eventually 
grew Salmonella group D. Blood culture and stool cul-
tures were sterile. Intravenous ciprofloxacin 200 mg 
every 12 hours was prescribed according to sensitiv-
ity test from the drainage culture and regular hemo-
dialysis was performed. Significant improvement in 
abdominal and flank pain was noted during treatment. 
Afterwards, the plasma glucose level was 89 mg/dL 
with no antidiabetic medicine. Intravenous ciproflox-
acin was replaced by oral ciprofloxacin on day 7. 
Revision of the drainage tube was performed twice 
during this period due to obstruction. A repeat cul-
ture continued to show Salmonella group D but with 
fewer flora. On day 14, she was discharged with oral 
ciprofloxacin for 2 weeks plus PCD for EPN. She re-
ceived regular hemodialysis at another hospital. Two 
weeks after discharge, she had a traffic accident re-
sulting in hematuria originating from the left kidney, 
and nephrectomy of the left kidney was performed 
due to persistent hematuria from the left kidney. 
Additionally, the PCD catheter was removed because 
of no drainage from the right kidney and oral cipro-
floxacin was prescribed for another 2 weeks. There 
was no fever, chills or other discomfort after removal 
of the catheter and nephrectomy. Two months later, 
she visited our outpatient clinic for follow-up and un-
enhanced renal CT showed neither gas nor necrotic 
tissue within the small right kidney (Fig. 2).
3. Discussion
EPN is a gas-producing, necrotizing infection of the 
kidney that results in the accumulation of air within 
the kidney [1–4]. More than three fourths of all reported 
cases of EPN occur in patients with DM [2,19], but it 
has been described in nondiabetic patients with UTO 
[2], renal allograft [12,18,20], horseshoe kidney [21], 
renal failure with renal cell carcinoma [13], and ESRD 
being treated with peritoneal dialysis [14]. Neither 
symptoms/signs nor laboratory data are useful in dis-
criminating EPN from acute pyelonephritis. The diagno-
sis of EPN is usually made by plain radiographs of the 
abdomen, renal ultrasound, and renal CT. However, 
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Fig. 1 — (A) Unenhanced computed tomography of the abdomen at the time of diagnosis shows air accumulation 
within a subcapsular collection at the posterior aspect of the enlarged right kidney. (B) A percutaneous catheter was 
inserted into the subcapsular collection of the right kidney for drainage.
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plain abdominal radiographs reveal gas within the renal 
parenchymal or perirenal space in only one third of 
EPN cases [4]. The diagnosis is always established 
via CT, which can also outline the extent of the infec-
tion and any associated obstructing lesions in the 
genitourinary tract.
The mechanism of gas formation and pathogenesis 
of EPN remain unclear, although serial studies have 
shown that four factors are involved in the pathogen-
esis of EPN [1–3,22–24]: (1) gas-forming bacteria; (2) a 
high tissue glucose level; (3) impaired tissue perfu sion 
(diabetic microangiopathy or UTO); and (4) a defec-
tive immune response. Hyperglycemia pro vides an 
abnormally high energy substrate for bacteria, facili-
tates rapid bacterial growth, and promotes mixed acid 
fermentation of glucose leading to increased gas for-
mation [24]. Diabetic microangiopathy or UTO may 
impair tissue perfusion leading to reduced gas elimi-
nation and decrease regional oxygen delivery to the 
kidney causing more obvious tissue ischemia and 
even necrosis. For example, a recent study investi-
gated the roles of host and bacterial virulence fac-
tors in the pathogenesis of EPN and found that DM 
with poor glycemic control and UTO with impaired 
renal circulation were the important host factors pre-
disposing patients to the development of EPN [1]. 
Also, there was no difference in gas production of 
Escherichia coli strains between EPN and non-EPN 
E. coli strains [1]. Additionally, an impaired vascular 
supply incurs a locally impaired host response.
Chronic uremic patients are susceptible to glucose 
intolerance, decreasing vascular supply to kidney, 
and immunodeficiency status. The immune system 
dysregulation in chronic uremic patients includes both 
the humor and cellular axes of immune systems, i.e. 
the chemotaxis of lymphocytes, monocytes and poly-
morphonuclear cells are perturbed to specific stimuli. 
However, it is surprising that only two EPN cases have 
been reported in patients with ESRD [13,14], although 
the predisposing factors of high tissue glucose level, 
presence of gas-forming microorganisms in the urinary 
tract, and infrequent emptying of the bladder second-
ary to oliguria are encountered frequently in patients 
with ESRD.
The most common microorganisms causing EPN 
is gas-forming E. coli (69%), followed by Klebsiella 
pneumoniae (29%) [2]. However, Proteus spp. [19], 
Citrobacter spp. [25], Candida spp. [26], Clostridium 
spp. [27], and Salmonella spp. [18] have also been 
reported as microorganisms in EPN. Extraintestinal 
infection from Salmonella is uncommon and UTI 
caused by Salmonella is particularly rare. Salmonella 
was reported as the cause of 0.056–0.07% of UTI in 
Spain [15,16], and 0.002–0.0037% of UTI in the United 
States [17]. UTI induced by Salmonella generally 
occurs in elderly patients with underlying diseases, 
especially DM, urologic abnormalities and immuno-
compromised conditions [15,16,28–30]. Therefore, the 
Salmonella-induced UTI in this uremic patient might 
be due to uremia-associated immunocompromise 
and/or urologic abnormality.
EPN is of special concern because of its life-
threatening potential and mortality associated with its 
treatment [2,31]. Treatment for EPN includes appro-
priate antibiotic therapy, therapy for septic shock, 
correction of the underlying hyperglycemia and elec-
trolyte disturbances, appropriate drainage via PCD and 
nephrectomy. Many studies stressed the high mortal-
ity rate (> 50%) of EPN and recommended that urgent 
nephrectomy or open drainage plus systemic antibi-
otics is mandatory [32–34]. However, the success of 
conservative treatment has improved substantially 
in recent years [2,35,36]. One study divided EPN into 
four classes according to the location of gas on CT 
scan and provided important guidelines for the man-
agement of EPN and improved mortality [2]. Class 1 
includes cases with gas in the collecting system only; 
Class 2, gas in the renal parenchyma without exten-
sion to the extrarenal space; Class 3A, extension of 
gas or abscess to the perinephric space; Class 3B, 
extension of gas or abscess to the pararenal space; 
Class 4, bilateral EPN or a solitary kidney with EPN 
[2]. The overall mortality rate was 18.8% with treat-
ment using the following two therapeutic guidelines: 
(1) antibiotics plus PCD for patients with local EPN 
(Classes 1 and 2) or extensive EPN patients (Classes 
3 and 4) with fewer than two risk factors (thrombo-
cytopenia, acute renal failure, consciousness distur-
bance, shock); (2) nephrectomy in selected patients 
with extensive EPN with more than two risk factors, 
or in patients who do not substantially improve after 
appropriate medical treatment and drainage [2].
Fig. 2 — Computed tomography scan 2 months after the 
patient had fully recovered shows neither gas nor necrotic 
tissue within the small right kidney and no left kidney 
because of left nephrectomy after a traffic accident.
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This case is rare and unique in that EPN caused 
by Salmonella occurred in an oliguric patient with 
ESRD but without DM or UTO. We believe that suc-
cessful treatment of EPN can be achieved by rapid 
diagnosis, full circulatory support, appropriate anti-
biotic therapy plus PCD for EPN, and nephrectomy if 
necessary.
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